HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 1,147: | Line 1,147: | ||
|[[HAEM5:Interdigitating dendritic cell sarcoma|Interdigitating dendritic cell sarcoma]] | |[[HAEM5:Interdigitating dendritic cell sarcoma|Interdigitating dendritic cell sarcoma]] | ||
|Disease | |Disease | ||
|Muhammad Zulfiqar, MD | |||
| | | | ||
| | | | ||
| | |Pending | ||
| | | | ||
|GC | |GC | ||
| Line 1,290: | Line 1,290: | ||
|[[HAEM5:Reactive B-cell rich lymphoid proliferations that can mimic lymphoma|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | |[[HAEM5:Reactive B-cell rich lymphoid proliferations that can mimic lymphoma|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | ||
|Disease | |Disease | ||
|Muhammad Zulfiqar, MD | |||
| | | | ||
| | | | ||
| | |Pending | ||
| | | | ||
|GC | |GC | ||
| Line 1,306: | Line 1,306: | ||
|[[HAEM5:IgG4-related disease|IgG4-related disease]] | |[[HAEM5:IgG4-related disease|IgG4-related disease]] | ||
|Disease | |Disease | ||
|Muhammad Zulfiqar, MD | |||
| | | | ||
| | | | ||
| | |Pending | ||
| | | | ||
|GC | |GC | ||
| Line 2,206: | Line 2,206: | ||
| | | | ||
|- | |- | ||
|[[HAEM5:Nodular lymphocyte predominant Hodgkin lymphoma|Nodular lymphocyte predominant Hodgkin lymphoma]]||Disease|| || || | | |[[HAEM5:Nodular lymphocyte predominant Hodgkin lymphoma|Nodular lymphocyte predominant Hodgkin lymphoma]]||Disease||Muhammad Zulfiqar, MD | ||
| || ||Pending|| ||GC|| || | |||
|NEW (No Prior) | |NEW (No Prior) | ||
|NEW (No Prior) | |NEW (No Prior) | ||